My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Nkarta, Inc. - Common Stock (NQ:NKTX)

1.820 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside ↗

July 18, 2022

Via Benzinga

Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments? ↗

June 14, 2022

Cell therapy — the use of stem cells and various engineered immune cells to target difficult-to-treat diseases like cancer and autoimmune conditions — has arguably been one of the big breakthroughs in...

Via Benzinga

Positive Clinical Results Put Nkarta Stock on the Fast Track ↗

May 09, 2022

NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program.

Via InvestorPlace

Executives Buy More Than $32M Of 3 Stocks ↗

May 02, 2022

Although US stocks closed sharply lower on Friday, there were a few notable insider trades.

Via Benzinga

How Is The Market Feeling About Nkarta Inc. - Common Stock? ↗

April 27, 2022

Nkarta Inc. - Common Stock's (NASDAQ:NKTX) short percent of float has risen 8.05% since its last report. The company recently reported that it has 1.84 million shares sold short,...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

April 26, 2022

Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday...

Via Benzinga

Expert Ratings for Nkarta ↗

April 26, 2022

Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter:

Via Benzinga

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

Futures Slide Ahead Of Tech Earnings Deluge ↗

April 26, 2022

Markets in general are preoccupied by the prospect of tighter monetary policy conditions from global central banks to stem rising prices.

Via Talk Markets

Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses ↗

April 25, 2022

Via Benzinga

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy ↗

April 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 26, 2022

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

April 26, 2022

HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide ↗

April 25, 2022

U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 26, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 25, 2022

Via Benzinga

Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher ↗

April 25, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 25, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...

Via Benzinga

Why Is Nkarta (NKTX) Stock Soaring 90% Today? ↗

April 25, 2022

Nkarta (NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical trial.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗

April 25, 2022

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More ↗

April 25, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

How Nkarta Stock Scored A 90% Surge On Its 'Natural Killers' In Cancer ↗

April 25, 2022

The biotech reported promising results for cell therapies without extreme side effects.

Via Investor's Business Daily

Why Nkarta Stock Is Soaring Today ↗

April 25, 2022

Nkarta Inc (NASDAQ: NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies. The...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

43 Stocks Moving In Tuesday's Mid-Day Session ↗

March 22, 2022

Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...

Via Benzinga

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

28 Stocks Moving In Friday's Mid-Day Session ↗

October 08, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.